ArticleCancer medicine2026

Survival Trends and Prognostic Modeling in ALK-Positive Anaplastic Large Cell Lymphoma: A Population-Based Study in the Brentuximab Vedotin Era.

Qiuyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.